{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T02:12:47Z","timestamp":1678155167410},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.0470","type":"journal-article","created":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T23:13:17Z","timestamp":1379200397000},"page":"2099-2103","source":"Crossref","is-referenced-by-count":3,"title":["Thrombotic Microangiopathy Secondary to Steroid Pulse Therapy Administered for Refractory Nephrotic Syndrome"],"prefix":"10.2169","volume":"52","author":[{"given":"Tomotsune","family":"Miyamoto","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozo","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Yamamura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Kawata","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Besbas N, Karpman D, Landau D, et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70: 423-431, 2006.","DOI":"10.1038\/sj.ki.5001581"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Denton CP, Lapadula G, Mounthon L, Müller-Ladner U. Renal complications and scleroderma renal crisis. Rheumatology 48: iii32-iii35, 2009.","DOI":"10.1093\/rheumatology\/ken483"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yoshioka K, Hattori T, Isaka Y, et al. Thrombotic microangiopathy due to malignant hypertension following corticosteroid therapy for microscopic polyangiitis. Intern Med 46: 785-788, 2007.","DOI":"10.2169\/internalmedicine.46.6291"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ishikawa Y, Nishio S, Sasaki H, et al. Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease. Clin Exp Nephrol 15: 179-183, 2011.","DOI":"10.1007\/s10157-010-0376-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Raman KG, Gandley RE, Rohland J, et al. Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide. J Vasc Surg 53: 754-763, 2011.","DOI":"10.1016\/j.jvs.2010.09.038"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mahmoodi BK, ten Kate MK, Waanders F, et al. High absolute risks and predictors of venous and arterial thoromboembolic events in patients with nephrotic syndrome. Circulation 117: 224-230, 2008.","DOI":"10.1161\/CIRCULATIONAHA.107.716951"},{"key":"7","unstructured":"7. Morita S, Sakai T, Okamoto N, et al. Hemolytic uremic syndrome associated with immunoglobulin A nephropathy: a case report and review of cases of hemolytic uremic syndrome with glomerular disease. Intern Med 38: 495-499, 1999."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Malyszko J, Malyszko JS, Mysliwiec M. Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome. Blood Coagul Fibrinolysis 13: 615-621, 2002.","DOI":"10.1097\/00001721-200210000-00006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lewis GD, Campbell WB, Johnson AR. Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells. Endocrinology 119: 62-69, 1986.","DOI":"10.1210\/endo-119-1-62"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Balkaya M, Prinz V, Custodis F, et al. Stress worsens endothelial function and ischemic stroke via glucocorticoids. Stroke 42: 3258-3264, 2011.","DOI":"10.1161\/STROKEAHA.110.607705"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Scully M, Hunt BJ, Benjamin S, et al. British Committee for Standards in Haematology. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 158: 323-335, 2012.","DOI":"10.1111\/j.1365-2141.2012.09167.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yokoyama H, Wada T, Zhang W, Yamaya H, Asaka M. Advances in apheresis therapy for glomerular disease. Clin Exp Nephrol 11: 122-127, 2007.","DOI":"10.1007\/s10157-007-0462-y"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/18\/52_52.0470\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:46:59Z","timestamp":1621446419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/18\/52_52.0470\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":12,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.0470","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}